Antihypertensive activity |
The antihypertensive activity of goat milk hydrolysate rich in TGPIPN, SLPQ, SQPK was studied in SHR. The SHR fed for 12 wk a diet enriched in a hydrolysate containing these peptides showed lower (approximately 15 mmHg) systolic blood pressure than animals fed a control diet, so the peptide SLPQ was a potential antihypertensive peptide (data not shown).
Table 1. Changes in BW, organ weight, food intake, and feeding efficiency of rats fed different diets 1
Item
| GP-control
| GP-hyd
| Captopril
| Initial BW, g
| 142.0 ± 4.9
| 152.0 ± 3.6
| 141.9 ± 4.9
| Final BW, g
| 263.0 ± 9.7
| 212.2 ± 7.0**
| 270.0 ± 6.4
| Heart weight, mg
| 948 ± 31
| 711 ± 33** | 816 ± 31** | Left ventricle weight, mg
| 690 ± 23
| 512 ± 22** | 572 ± 27** | Kidney weight, mg
| 924 ± 48
| 616 ± 28** | 861 ± 22
| Weight gain, g/rat per d
| 1.44 ± 0.08
| 0.72 ± 0.06** | 1.56 ± 0.04
| Food intake, g/rat per d
| 17.5 ± 0.3 | 18.1 ± 0.5
| 21.8 ± 0.6** | Feeding efficiency 2, %
| 8.24 ± 0.44
| 3.97 ± 0.31** | 7.17 ± 0.17** | 1 Values are means ± SEM (n = 10). 2 Feeding efficiency = (daily weight gain/daily food intake) × 100. GP-control = diet containing goat protein; GP-hyd = ad libitum diet containing goat protein hydrolysate; captopril = diet containing goat protein and captopril. ** P < 0.01 vs. GP-control group. | |
Specific target protein(s) |
N.D |